Product image of Medrol (Methylprednisolone) supplied by GNH India

Medrol

Active Ingredient:
Methylprednisolone
Origin:
EU

Medrol (Methylprednisolone)

Methylprednisolone, the active ingredient in Medrol, is a corticosteroid presented as an oral tablet for oral use. It provides anti‑inflammatory and immunosuppressive effects and is prescribed for a range of allergic, respiratory and autoimmune conditions in both adults and children as directed by a healthcare professional.

GNH India supplies Medrol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pfizer Oy

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medrol is a corticosteroid that modulates inflammatory and immune pathways across several disease families.

  • Allergic disorders: reduces inflammation and alleviates symptoms such as swelling, itching and hives.
  • Asthma: diminishes airway inflammation, improving breathing and reducing exacerbations.
  • Rheumatoid arthritis: decreases joint inflammation and pain, helping preserve mobility.
  • Dermatologic diseases: controls severe skin inflammation in conditions like eczema and psoriasis.
  • Autoimmune conditions: suppresses immune over‑activity in diseases such as systemic lupus erythematosus.

How It Works

  • Methylprednisolone binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and regulates gene transcription. This interaction up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, leading to reduced leukocyte migration, decreased capillary permeability, and overall suppression of immune responses.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Increased appetite or weight gain.
  • Elevated blood glucose levels.
  • Mood changes, including anxiety or insomnia.
  • Gastrointestinal discomfort such as nausea or indigestion.
  • Fluid retention causing mild swelling.

Serious or Rare Side Effects

  • Severe infections due to immunosuppression.
  • Osteoporosis or bone fractures with long‑term use.
  • Adrenal insufficiency upon abrupt discontinuation.
  • Vision problems such as cataracts or glaucoma.
  • Uncontrolled hypertension or cardiovascular events.

Precautions & Warnings

Before initiating therapy, consider the following safety measures.

  • Assess infection risk: avoid use in active, uncontrolled infections.
  • Monitor blood glucose: patients with diabetes may need dose adjustments.
  • Evaluate bone health: consider calcium and vitamin D supplementation for long‑term therapy.
  • Screen for psychiatric history: corticosteroids can exacerbate mood disorders.
  • Review gastrointestinal history: use with caution in patients with peptic ulcer disease.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Methylprednisolone may alter the activity of several concomitant medicines.

Major Interactions (Avoid)

  • Strong CYP3A4 inducers (e.g., rifampin, phenytoin) that may reduce steroid efficacy.
  • Live vaccines: increased risk of disseminated infection.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): heightened risk of gastrointestinal bleeding.
  • Anticoagulants (warfarin): possible enhancement of anticoagulant effect.
  • Diabetic agents: may require dose adjustments due to altered glucose control.
  • Antihypertensives: corticosteroids can blunt blood‑pressure‑lowering effects.

Frequently Asked Questions

Medrol, containing methylprednisolone, is prescribed for a variety of inflammatory and immune‑mediated conditions such as allergic reactions, asthma, rheumatoid arthritis, severe skin disorders and other autoimmune diseases. The specific indication depends on the patient’s clinical presentation and the prescribing physician’s assessment.

Methylprednisolone binds to glucocorticoid receptors inside cells, altering gene expression. This leads to increased production of anti‑inflammatory proteins and suppression of pro‑inflammatory cytokines, thereby reducing swelling, pain, and immune system activity that underlie many chronic inflammatory disorders.

The dosage of Medrol is individualized by the prescribing clinician based on the condition being treated, severity, patient weight, age and response to therapy. Patients should follow the exact dosing instructions provided by their healthcare professional and not adjust the dose on their own.

The safety of methylprednisolone in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and this decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the Medrol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medrol (methylprednisolone) is a medium‑potency glucocorticoid with a relatively rapid onset of action compared with some alternatives like prednisone. Its pharmacokinetic profile may allow for shorter courses in certain acute inflammatory settings, while still providing comparable anti‑inflammatory efficacy.

Medrol tablets should be stored at ambient temperature, preferably below 25 °C. Keep the medication in its original container, protect it from moisture and direct sunlight, and ensure that it is out of reach of children.

Medrol is taken orally, usually with food or a glass of water to reduce gastrointestinal irritation. The exact administration schedule—such as once daily or divided doses—will be determined by the prescribing clinician based on the therapeutic need.

Serious risks include severe infections due to immune suppression, adrenal insufficiency if the drug is stopped abruptly after prolonged use, osteoporosis with long‑term therapy, and potential cardiovascular complications such as hypertension or fluid retention.

Medrol is contraindicated in patients with systemic fungal infections, known hypersensitivity to methylprednisolone or any formulation component, and those receiving live vaccines. Caution is also advised for individuals with uncontrolled diabetes, active peptic ulcer disease, or severe psychiatric disorders.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylprednisolone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT